These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21696712)

  • 41. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    Touil T; Ciric B; Ventura E; Shindler KS; Gran B; Rostami A
    J Neurol Sci; 2008 Aug; 271(1-2):191-202. PubMed ID: 18544456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis.
    Nicolò C; Sali M; Di Sante G; Geloso MC; Signori E; Penitente R; Uniyal S; Rinaldi M; Ingrosso L; Fazio VM; Chan BM; Delogu G; Ria F
    J Immunol; 2010 Jan; 184(1):222-35. PubMed ID: 19949067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation.
    Katsara M; Deraos S; Tselios TV; Pietersz G; Matsoukas J; Apostolopoulos V
    Immunotherapy; 2014; 6(6):709-24. PubMed ID: 25186603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG oligonucleotide.
    Smolianov V; Dehmel T; Vollmar P; Mausberg AK; Kieseier BC; Hemmer B; Hartung HP; Hofstetter HH
    J Neuroinflammation; 2011 May; 8():59. PubMed ID: 21624133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
    Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA
    J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
    Ponomarev ED; Novikova M; Yassai M; Szczepanik M; Gorski J; Dittel BN
    J Immunol; 2004 Aug; 173(3):1587-95. PubMed ID: 15265886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
    Peng Y; Liu CP
    Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.
    Fitzgerald DC; Ciric B; Touil T; Harle H; Grammatikopolou J; Das Sarma J; Gran B; Zhang GX; Rostami A
    J Immunol; 2007 Sep; 179(5):3268-75. PubMed ID: 17709543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential recognition of peptide analogs by naive verses activated PLP 139-151-specific CD4+ T cells.
    McRae BL; Nikcevich KM; Karpus WJ; Hurst SD; Miller SD
    J Neuroimmunol; 1995 Jul; 60(1-2):17-28. PubMed ID: 7543908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SJL mice infected with Acanthamoeba castellanii develop central nervous system autoimmunity through the generation of cross-reactive T cells for myelin antigens.
    Massilamany C; Marciano-Cabral F; Rocha-Azevedo Bd; Jamerson M; Gangaplara A; Steffen D; Zabad R; Illes Z; Sobel RA; Reddy J
    PLoS One; 2014; 9(5):e98506. PubMed ID: 24879066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
    Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
    J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
    Aharoni R; Eilam R; Stock A; Vainshtein A; Shezen E; Gal H; Friedman N; Arnon R
    J Neuroimmunol; 2010 Aug; 225(1-2):100-11. PubMed ID: 20554028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
    Bischof F; Hofmann M; Schumacher TN; Vyth-Dreese FA; Weissert R; Schild H; Kruisbeek AM; Melms A
    J Immunol; 2004 Mar; 172(5):2878-84. PubMed ID: 14978089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.